SlideShare a Scribd company logo
1 of 16
Download to read offline
Editorial Slides
VP Watch, February 26, 2003, Volume 3, Issue 8
Cholesterol Independent
Therapeutic Effects of HDL
Morteza Naghavi, MD
–The inverse correlation between
high-density lipoproteins (HDL) and
cardiovascular atherosclerotic
disease is “well known”.
–However, the underlying
mechanisms of actions for
beneficial effects of HDL remain to
be completely elucidated.
–Although HDL acts mainly by
reversing the cholesterol transport
and inhibiting the oxidation of low-
density lipoproteins, several lines of
evidence suggest that HDL can also
act directly in cholesterol-
independent ways including
inhibition of endothelial cell
adhesion molecule expression1
and
facilitating release of prostacyclin2
from endothelial cells.
–Besides being a strong independent
predictor of the occurrence of
primary coronary events, a low
plasma HDL cholesterol level is also
associated with unfavorable
prognosis in patients who have
recovered from a myocardial
infarction. 5
–Whether this association reflects
accelerated atherogenesis or a direct
detrimental effect of a low HDL level on
postischemic myocardial function is
unknown.
–A low HDL level adversely influences
postinfarct left ventricular function in
patients with a first myocardial infarction,
independent of the severity of coronary
atherosclerosis6.
–As featured in VP Watch of this
week, Calabresi et al3
investigated
the possible direct cardio protective
effect of HDL administered 10
minutes before ischemia on the
isolated rat heart which underwent
20-minute low-flow ischemia
followed by a 30-minute
reperfusion.
The analyzed the following parameters:
– postischemic functional recovery,
– creatine kinase release in the coronary
effluent,
– expression and content of tumor necrosis
factor-α in the myocardium and
– coronary effluent and prostaglandin release.
In addition, the effect of the recombinant
TNF- α-blocking protein etanercept on
the functional recovery was also
studied.
Control
This figure shows the changes in cardiac function recovery in rat hearts perfused with saline (circles),This figure shows the changes in cardiac function recovery in rat hearts perfused with saline (circles),
HDLs at 0.5 mg/ml (triangles) and 1.0 mg/ml (inverted triangles).HDLs at 0.5 mg/ml (triangles) and 1.0 mg/ml (inverted triangles).
LVDP indicates left ventricular developed pressure; CPP, coronary perfusion pressure..LVDP indicates left ventricular developed pressure; CPP, coronary perfusion pressure..
HDL showed a dose-dependent beneficialHDL showed a dose-dependent beneficial
effect on cardiac functioneffect on cardiac function
Increase in
HDL dose
Etanercept caused a dose-dependent improvement in functional recovery. The
lipid-free apoA-I did not reproduce the effects of HDL. Reconstituted HDL
containing apoA-I and phosphatidylcholine. However, had the same effect as
native HDL.
HDL increased prostaglandin release in the
coronary effluent in a dose-dependent
manner
– In an accompanying editorial in Circulation Research, Dipak
Das4
discussed all the known possible scenarios that contribute to
the effect of HDL on cardio-protection from ischemia/reperfusion
injury.
Conclusion:
• HDL exerts multiple beneficial
effects on parameters involved
in ischemia/reperfusion
mediated cardiac injury.
• This may have major
therapeutic implications in the
near future.
Question:
• What could be the underlying
mechanism(s) for direct cardio-
protective effect of HDL on
myocardium?
–Anti-inflammatory?
–Anti-oxidant?
–Anti-Apoptotic?
–Cholesterol reverse transfer?
Question:
• Is the anti-inflammatory effect of
HDL specific to ischemia-
reperfusion injury of myocardial
cells or it can exerts similar
effects on other types of cells
and tissues as well?
Question:
• As far as reducing adverse
cardiovascular events, do you
think the cardio-protective effect
of HDL may turn out to be more
important than its anti-
atherosclerotic effect?
Question:
• Since HDL has some degree of
protective effect against stroke,
is it safe to assume that anti-
atherosclerotic effect of HDL in
coronary heart disease may be
equal to its anti-stroke effect?

More Related Content

What's hot

Hypertension & Anti-hypertensive drugs
Hypertension & Anti-hypertensive drugsHypertension & Anti-hypertensive drugs
Hypertension & Anti-hypertensive drugsrajivkumal
 
Drugs in sports97 03
Drugs in sports97 03Drugs in sports97 03
Drugs in sports97 03Queency Ramos
 
Blood transfusion-MANAGEMENT FOR PEOPLE LIVING WITH SICKLE CELL DISORDER/DISE...
Blood transfusion-MANAGEMENT FOR PEOPLE LIVING WITH SICKLE CELL DISORDER/DISE...Blood transfusion-MANAGEMENT FOR PEOPLE LIVING WITH SICKLE CELL DISORDER/DISE...
Blood transfusion-MANAGEMENT FOR PEOPLE LIVING WITH SICKLE CELL DISORDER/DISE...martinshaji
 
Anticoagulants
AnticoagulantsAnticoagulants
AnticoagulantsKazi Ornob
 
Chemical Bonds
Chemical BondsChemical Bonds
Chemical BondsLuna55555
 
Levosimendan
LevosimendanLevosimendan
Levosimendannmonty02
 
Blood Doping Powerpoint
Blood Doping PowerpointBlood Doping Powerpoint
Blood Doping Powerpointkylmch1
 
Anemia in ckd patients 1
Anemia in ckd patients 1Anemia in ckd patients 1
Anemia in ckd patients 1FarragBahbah
 
Blood dopping, defination, methods, detection, pros/cons.
Blood dopping, defination, methods, detection, pros/cons.Blood dopping, defination, methods, detection, pros/cons.
Blood dopping, defination, methods, detection, pros/cons.Hiba Nasir
 
Cardiac glycosides final
Cardiac glycosides finalCardiac glycosides final
Cardiac glycosides finalShubhamBhople3
 
The seven common diseases powerpoint
The seven common diseases powerpointThe seven common diseases powerpoint
The seven common diseases powerpointlailafernandez2
 
Polycythemia - increase in RBC count
Polycythemia - increase in RBC countPolycythemia - increase in RBC count
Polycythemia - increase in RBC countHarshal Roy
 
Regeneration of cardiomiocytes by using bone marrow derived
Regeneration of cardiomiocytes by using bone marrow derivedRegeneration of cardiomiocytes by using bone marrow derived
Regeneration of cardiomiocytes by using bone marrow derivedpabloandresgonz
 
Cardiovascular aessessment
Cardiovascular aessessmentCardiovascular aessessment
Cardiovascular aessessmentYaserAlikhajeh1
 

What's hot (19)

Hypertension & Anti-hypertensive drugs
Hypertension & Anti-hypertensive drugsHypertension & Anti-hypertensive drugs
Hypertension & Anti-hypertensive drugs
 
atherosclerosis
atherosclerosisatherosclerosis
atherosclerosis
 
Drugs in sports97 03
Drugs in sports97 03Drugs in sports97 03
Drugs in sports97 03
 
Blood transfusion-MANAGEMENT FOR PEOPLE LIVING WITH SICKLE CELL DISORDER/DISE...
Blood transfusion-MANAGEMENT FOR PEOPLE LIVING WITH SICKLE CELL DISORDER/DISE...Blood transfusion-MANAGEMENT FOR PEOPLE LIVING WITH SICKLE CELL DISORDER/DISE...
Blood transfusion-MANAGEMENT FOR PEOPLE LIVING WITH SICKLE CELL DISORDER/DISE...
 
Anticoagulants
AnticoagulantsAnticoagulants
Anticoagulants
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Chemical Bonds
Chemical BondsChemical Bonds
Chemical Bonds
 
EPO
EPOEPO
EPO
 
Levosimendan
LevosimendanLevosimendan
Levosimendan
 
Blood Doping Powerpoint
Blood Doping PowerpointBlood Doping Powerpoint
Blood Doping Powerpoint
 
Anemia in ckd patients 1
Anemia in ckd patients 1Anemia in ckd patients 1
Anemia in ckd patients 1
 
Blood dopping, defination, methods, detection, pros/cons.
Blood dopping, defination, methods, detection, pros/cons.Blood dopping, defination, methods, detection, pros/cons.
Blood dopping, defination, methods, detection, pros/cons.
 
Cardiac glycosides final
Cardiac glycosides finalCardiac glycosides final
Cardiac glycosides final
 
Chapter018
Chapter018Chapter018
Chapter018
 
The seven common diseases powerpoint
The seven common diseases powerpointThe seven common diseases powerpoint
The seven common diseases powerpoint
 
Blood Doping in Athletics
Blood Doping in AthleticsBlood Doping in Athletics
Blood Doping in Athletics
 
Polycythemia - increase in RBC count
Polycythemia - increase in RBC countPolycythemia - increase in RBC count
Polycythemia - increase in RBC count
 
Regeneration of cardiomiocytes by using bone marrow derived
Regeneration of cardiomiocytes by using bone marrow derivedRegeneration of cardiomiocytes by using bone marrow derived
Regeneration of cardiomiocytes by using bone marrow derived
 
Cardiovascular aessessment
Cardiovascular aessessmentCardiovascular aessessment
Cardiovascular aessessment
 

Viewers also liked

091 vascular dysfunction in hypercholesterolemic rabbits
091 vascular dysfunction in hypercholesterolemic rabbits091 vascular dysfunction in hypercholesterolemic rabbits
091 vascular dysfunction in hypercholesterolemic rabbitsSHAPE Society
 
134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imagingSHAPE Society
 
058 optical coherence tomography
058 optical coherence tomography058 optical coherence tomography
058 optical coherence tomographySHAPE Society
 
086 unstable angina, lad stenosis
086 unstable angina, lad stenosis086 unstable angina, lad stenosis
086 unstable angina, lad stenosisSHAPE Society
 
160 5th vulnerable plaque symposium
160 5th vulnerable plaque symposium160 5th vulnerable plaque symposium
160 5th vulnerable plaque symposiumSHAPE Society
 
256 spatial encoding part 2
256 spatial encoding part 2256 spatial encoding part 2
256 spatial encoding part 2SHAPE Society
 
050 periadventitial fat
050 periadventitial fat050 periadventitial fat
050 periadventitial fatSHAPE Society
 
179 chlamydophila pneumoniae
179 chlamydophila pneumoniae179 chlamydophila pneumoniae
179 chlamydophila pneumoniaeSHAPE Society
 
504 percutaneouse coronary intervention
504 percutaneouse coronary intervention504 percutaneouse coronary intervention
504 percutaneouse coronary interventionSHAPE Society
 
220 statin therapy and coronary calcification
220 statin therapy and coronary calcification220 statin therapy and coronary calcification
220 statin therapy and coronary calcificationSHAPE Society
 
038 tct arrow pics, landscape
038 tct arrow pics, landscape038 tct arrow pics, landscape
038 tct arrow pics, landscapeSHAPE Society
 
092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosisSHAPE Society
 
247 ebct vs conventional risk factors
247 ebct vs conventional risk factors247 ebct vs conventional risk factors
247 ebct vs conventional risk factorsSHAPE Society
 

Viewers also liked (20)

091 vascular dysfunction in hypercholesterolemic rabbits
091 vascular dysfunction in hypercholesterolemic rabbits091 vascular dysfunction in hypercholesterolemic rabbits
091 vascular dysfunction in hypercholesterolemic rabbits
 
165 pressure wire
165 pressure wire165 pressure wire
165 pressure wire
 
134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging
 
058 optical coherence tomography
058 optical coherence tomography058 optical coherence tomography
058 optical coherence tomography
 
086 unstable angina, lad stenosis
086 unstable angina, lad stenosis086 unstable angina, lad stenosis
086 unstable angina, lad stenosis
 
160 5th vulnerable plaque symposium
160 5th vulnerable plaque symposium160 5th vulnerable plaque symposium
160 5th vulnerable plaque symposium
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
 
256 spatial encoding part 2
256 spatial encoding part 2256 spatial encoding part 2
256 spatial encoding part 2
 
1031 talk2
1031 talk21031 talk2
1031 talk2
 
050 periadventitial fat
050 periadventitial fat050 periadventitial fat
050 periadventitial fat
 
179 chlamydophila pneumoniae
179 chlamydophila pneumoniae179 chlamydophila pneumoniae
179 chlamydophila pneumoniae
 
Barth imt
Barth imtBarth imt
Barth imt
 
504 percutaneouse coronary intervention
504 percutaneouse coronary intervention504 percutaneouse coronary intervention
504 percutaneouse coronary intervention
 
220 statin therapy and coronary calcification
220 statin therapy and coronary calcification220 statin therapy and coronary calcification
220 statin therapy and coronary calcification
 
148 the erythrocyte
148 the erythrocyte148 the erythrocyte
148 the erythrocyte
 
038 tct arrow pics, landscape
038 tct arrow pics, landscape038 tct arrow pics, landscape
038 tct arrow pics, landscape
 
092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis092 il18 and il18 bp in atherosclerosis
092 il18 and il18 bp in atherosclerosis
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
 
254 nanotechnology
254 nanotechnology254 nanotechnology
254 nanotechnology
 
247 ebct vs conventional risk factors
247 ebct vs conventional risk factors247 ebct vs conventional risk factors
247 ebct vs conventional risk factors
 

Similar to 181 cholesterol independent therapeutic effects of hdl

Heart Failure (HF)
Heart Failure (HF)Heart Failure (HF)
Heart Failure (HF)Divya Watson
 
ACTUALIZACIÓN EN LÍPIDOS Y ARTERIOSCLEROSIS 2011. LLUIS MASANA. XIV JORNADA D...
ACTUALIZACIÓN EN LÍPIDOS Y ARTERIOSCLEROSIS 2011. LLUIS MASANA. XIV JORNADA D...ACTUALIZACIÓN EN LÍPIDOS Y ARTERIOSCLEROSIS 2011. LLUIS MASANA. XIV JORNADA D...
ACTUALIZACIÓN EN LÍPIDOS Y ARTERIOSCLEROSIS 2011. LLUIS MASANA. XIV JORNADA D...La SEA
 
Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesi...
Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesi...Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesi...
Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesi...My Healthy Waist
 
Revisiting the Diet Heart Disease Hypothesis Paper
Revisiting the Diet Heart Disease Hypothesis PaperRevisiting the Diet Heart Disease Hypothesis Paper
Revisiting the Diet Heart Disease Hypothesis PaperDr. Alex Rinehart
 
Role of lipid profile in the short term prognosis of acute myocardial infarct...
Role of lipid profile in the short term prognosis of acute myocardial infarct...Role of lipid profile in the short term prognosis of acute myocardial infarct...
Role of lipid profile in the short term prognosis of acute myocardial infarct...Apollo Hospitals
 
Raising HDL cholesterol – The Controversy
Raising HDL cholesterol – The ControversyRaising HDL cholesterol – The Controversy
Raising HDL cholesterol – The ControversyShashikiran Umakanth
 
Potential new therapies in heart failure
Potential new therapies in heart failurePotential new therapies in heart failure
Potential new therapies in heart failureAnirudhya J
 
253 endothelial dysfunction
253 endothelial dysfunction253 endothelial dysfunction
253 endothelial dysfunctionSHAPE Society
 
CETP inhibitors Future in lipid management
CETP inhibitors Future in lipid managementCETP inhibitors Future in lipid management
CETP inhibitors Future in lipid managementVeerendra Singh
 
The Unmet Medical Need in Homozygous Familial Hypercholesterolemia by Dennis ...
The Unmet Medical Need in Homozygous Familial Hypercholesterolemia by Dennis ...The Unmet Medical Need in Homozygous Familial Hypercholesterolemia by Dennis ...
The Unmet Medical Need in Homozygous Familial Hypercholesterolemia by Dennis ...CrimsonPublishersGJEM
 
Cholesterol metabolism (2)
Cholesterol metabolism (2)Cholesterol metabolism (2)
Cholesterol metabolism (2)Mahdi Albakaa
 
Focus on high density lipoproteins
Focus on high density lipoproteinsFocus on high density lipoproteins
Focus on high density lipoproteinsSachin Verma
 
Optimal%20management%20 hta%202011%20ehj
Optimal%20management%20 hta%202011%20ehjOptimal%20management%20 hta%202011%20ehj
Optimal%20management%20 hta%202011%20ehjManuel Sanchez Molla
 
Classes of lipoproteins and their role in the
Classes of lipoproteins and their role in the Classes of lipoproteins and their role in the
Classes of lipoproteins and their role in the Fikri Abdullah Zawawi
 
Drugs used in hypertension
Drugs used in hypertensionDrugs used in hypertension
Drugs used in hypertensionGoutam Mallik
 

Similar to 181 cholesterol independent therapeutic effects of hdl (20)

Heart Failure (HF)
Heart Failure (HF)Heart Failure (HF)
Heart Failure (HF)
 
ACTUALIZACIÓN EN LÍPIDOS Y ARTERIOSCLEROSIS 2011. LLUIS MASANA. XIV JORNADA D...
ACTUALIZACIÓN EN LÍPIDOS Y ARTERIOSCLEROSIS 2011. LLUIS MASANA. XIV JORNADA D...ACTUALIZACIÓN EN LÍPIDOS Y ARTERIOSCLEROSIS 2011. LLUIS MASANA. XIV JORNADA D...
ACTUALIZACIÓN EN LÍPIDOS Y ARTERIOSCLEROSIS 2011. LLUIS MASANA. XIV JORNADA D...
 
Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesi...
Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesi...Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesi...
Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesi...
 
Revisiting the Diet Heart Disease Hypothesis Paper
Revisiting the Diet Heart Disease Hypothesis PaperRevisiting the Diet Heart Disease Hypothesis Paper
Revisiting the Diet Heart Disease Hypothesis Paper
 
Role of lipid profile in the short term prognosis of acute myocardial infarct...
Role of lipid profile in the short term prognosis of acute myocardial infarct...Role of lipid profile in the short term prognosis of acute myocardial infarct...
Role of lipid profile in the short term prognosis of acute myocardial infarct...
 
Raising HDL cholesterol – The Controversy
Raising HDL cholesterol – The ControversyRaising HDL cholesterol – The Controversy
Raising HDL cholesterol – The Controversy
 
1246.full.pdf
1246.full.pdf1246.full.pdf
1246.full.pdf
 
Potential new therapies in heart failure
Potential new therapies in heart failurePotential new therapies in heart failure
Potential new therapies in heart failure
 
253 endothelial dysfunction
253 endothelial dysfunction253 endothelial dysfunction
253 endothelial dysfunction
 
Stroes
StroesStroes
Stroes
 
253 endothelial dysfunction
253 endothelial dysfunction253 endothelial dysfunction
253 endothelial dysfunction
 
Sympatholytic drugs
Sympatholytic drugsSympatholytic drugs
Sympatholytic drugs
 
CETP inhibitors Future in lipid management
CETP inhibitors Future in lipid managementCETP inhibitors Future in lipid management
CETP inhibitors Future in lipid management
 
The Unmet Medical Need in Homozygous Familial Hypercholesterolemia by Dennis ...
The Unmet Medical Need in Homozygous Familial Hypercholesterolemia by Dennis ...The Unmet Medical Need in Homozygous Familial Hypercholesterolemia by Dennis ...
The Unmet Medical Need in Homozygous Familial Hypercholesterolemia by Dennis ...
 
Cholesterol metabolism (2)
Cholesterol metabolism (2)Cholesterol metabolism (2)
Cholesterol metabolism (2)
 
Focus on high density lipoproteins
Focus on high density lipoproteinsFocus on high density lipoproteins
Focus on high density lipoproteins
 
Optimal%20management%20 hta%202011%20ehj
Optimal%20management%20 hta%202011%20ehjOptimal%20management%20 hta%202011%20ehj
Optimal%20management%20 hta%202011%20ehj
 
Classes of lipoproteins and their role in the
Classes of lipoproteins and their role in the Classes of lipoproteins and their role in the
Classes of lipoproteins and their role in the
 
Drugs used in hypertension
Drugs used in hypertensionDrugs used in hypertension
Drugs used in hypertension
 
My Research Article
My Research ArticleMy Research Article
My Research Article
 

More from SHAPE Society

Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stoneSHAPE Society
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 fSHAPE Society
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)SHAPE Society
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)SHAPE Society
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)SHAPE Society
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for printSHAPE Society
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for printSHAPE Society
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermographySHAPE Society
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st centurySHAPE Society
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosisSHAPE Society
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factorSHAPE Society
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understandingSHAPE Society
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02SHAPE Society
 

More from SHAPE Society (20)

Braunwald
BraunwaldBraunwald
Braunwald
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
A20 gene
A20 geneA20 gene
A20 gene
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
 
103100
103100103100
103100
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factor
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understanding
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02
 

Recently uploaded

Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxSasikiranMarri
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfHongBiThi1
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 

Recently uploaded (20)

Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 

181 cholesterol independent therapeutic effects of hdl

  • 1. Editorial Slides VP Watch, February 26, 2003, Volume 3, Issue 8 Cholesterol Independent Therapeutic Effects of HDL Morteza Naghavi, MD
  • 2. –The inverse correlation between high-density lipoproteins (HDL) and cardiovascular atherosclerotic disease is “well known”. –However, the underlying mechanisms of actions for beneficial effects of HDL remain to be completely elucidated.
  • 3. –Although HDL acts mainly by reversing the cholesterol transport and inhibiting the oxidation of low- density lipoproteins, several lines of evidence suggest that HDL can also act directly in cholesterol- independent ways including inhibition of endothelial cell adhesion molecule expression1 and facilitating release of prostacyclin2 from endothelial cells.
  • 4. –Besides being a strong independent predictor of the occurrence of primary coronary events, a low plasma HDL cholesterol level is also associated with unfavorable prognosis in patients who have recovered from a myocardial infarction. 5
  • 5. –Whether this association reflects accelerated atherogenesis or a direct detrimental effect of a low HDL level on postischemic myocardial function is unknown. –A low HDL level adversely influences postinfarct left ventricular function in patients with a first myocardial infarction, independent of the severity of coronary atherosclerosis6.
  • 6. –As featured in VP Watch of this week, Calabresi et al3 investigated the possible direct cardio protective effect of HDL administered 10 minutes before ischemia on the isolated rat heart which underwent 20-minute low-flow ischemia followed by a 30-minute reperfusion.
  • 7. The analyzed the following parameters: – postischemic functional recovery, – creatine kinase release in the coronary effluent, – expression and content of tumor necrosis factor-α in the myocardium and – coronary effluent and prostaglandin release. In addition, the effect of the recombinant TNF- α-blocking protein etanercept on the functional recovery was also studied.
  • 8. Control This figure shows the changes in cardiac function recovery in rat hearts perfused with saline (circles),This figure shows the changes in cardiac function recovery in rat hearts perfused with saline (circles), HDLs at 0.5 mg/ml (triangles) and 1.0 mg/ml (inverted triangles).HDLs at 0.5 mg/ml (triangles) and 1.0 mg/ml (inverted triangles). LVDP indicates left ventricular developed pressure; CPP, coronary perfusion pressure..LVDP indicates left ventricular developed pressure; CPP, coronary perfusion pressure.. HDL showed a dose-dependent beneficialHDL showed a dose-dependent beneficial effect on cardiac functioneffect on cardiac function Increase in HDL dose
  • 9. Etanercept caused a dose-dependent improvement in functional recovery. The lipid-free apoA-I did not reproduce the effects of HDL. Reconstituted HDL containing apoA-I and phosphatidylcholine. However, had the same effect as native HDL.
  • 10. HDL increased prostaglandin release in the coronary effluent in a dose-dependent manner
  • 11. – In an accompanying editorial in Circulation Research, Dipak Das4 discussed all the known possible scenarios that contribute to the effect of HDL on cardio-protection from ischemia/reperfusion injury.
  • 12. Conclusion: • HDL exerts multiple beneficial effects on parameters involved in ischemia/reperfusion mediated cardiac injury. • This may have major therapeutic implications in the near future.
  • 13. Question: • What could be the underlying mechanism(s) for direct cardio- protective effect of HDL on myocardium? –Anti-inflammatory? –Anti-oxidant? –Anti-Apoptotic? –Cholesterol reverse transfer?
  • 14. Question: • Is the anti-inflammatory effect of HDL specific to ischemia- reperfusion injury of myocardial cells or it can exerts similar effects on other types of cells and tissues as well?
  • 15. Question: • As far as reducing adverse cardiovascular events, do you think the cardio-protective effect of HDL may turn out to be more important than its anti- atherosclerotic effect?
  • 16. Question: • Since HDL has some degree of protective effect against stroke, is it safe to assume that anti- atherosclerotic effect of HDL in coronary heart disease may be equal to its anti-stroke effect?